Publications Rikus (H) Knegtering, MD PhD. Update May Publications in the Dutch language have an English translation added.

Size: px
Start display at page:

Download "Publications Rikus (H) Knegtering, MD PhD. Update May 2010. Publications in the Dutch language have an English translation added."

Transcription

1 Publications Rikus (H) Knegtering, MD PhD. Update May Publications in the Dutch language have an English translation added Vercammen A., Knegtering H., den Boer H., Liemburg E., Aleman A (2010). Auditory hallucinations in schizophrenia are associated with reduced functional connectivity of the temporo-parietal area. Biological psychiatry. 15;67(10): Epub 7 jan doi: /j.biopsych Westenbroek JM., Ouwehand J., Sytema, S., Wiersma D., Knegtering H (2010). Menstrual disorders in schizophrenia, possible causes and consequences (submitted). De Lange J, Kuipers M, Knegtering H (2010). Does the Critical Flicker Fusion Threshold distinguish patients with schizophrenia from healthy controls? (submitted). Knegtering H., Oolders H., Ruisink M., Moolen van der A.E.G.M (2010). Depot antipsychotica anno 2010 (Depot antipsychotics anno 2010). Nederlands Tijdschrift voor Geneeskunde (accepted). Jiawan V.C.R, Arends J., Slooff C., Knegtering H (2010). Medicamenteuze interventies bij negatieve symptomen bij patiënten met schizofrenie (Pharmacological interventions for negative symptoms in patients with schizophrenia). Nederlands Tijdschrift voor Psychiatrie (In press) Wolters H.A. (2010). Desired and undesired effects of antipsychotic treatment from a patients perspective: the psychometric evaluation of a self rating instrument. University of Groningen, The Netherlands. PhD Thesis. (http://irs.ub.rug.nl/ppn/ x) (supervision D. Wiersma (promotor), H. Knegtering (co-promotor). Boer de M.K., Bous J., Sytema S., Moolen van der AEGM, Hamamura T., Wilffert B., Bous, J., Wiersma D., Knegtering H. (2010). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study) (submitted). Castelein S., Bruggeman R., van Busschbach JT., Knegtering H., van der Gaag M., Wiersma D. Predictors of successful participation in peer support groups for psychosis (submitted). Liemburg E., Aleman A., Knegtering H (2010). Biologische achtergrond van negatieve symptomen bij schizofrenie (The biological background of negative symptoms in schizophrenia). In: Kenniscentrum schizofrenie boekenreeks (accepted). Dlabac-De Lange JJ., Knegtering H., Aleman A (2010). Rapid Transcranial Magnetic Stimulation (r- TMS) for negative and cognitive symptoms in schizophrenia, a meta-analyses. J Clin Psychiatry. 71(4): Feb 23. [Epub ahead of print]. Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Stant D., Knegtering H., Wiersma D (2010). Lotgenotengroepen voor mensen met psychosen: een gerandomiseerde en gecontroleerde studie (Pear support groups for people suffering from a psychotic illness, a randomized controlled trial). Geschreven op verzoek van het Nederlands Tijdschrift voor Geneeskunde (Written on request of the Dutch Journal of Medecine) (In press). Liemburg E., Swart M., Curcic-Blake B., Knegtering H., Aleman A. Altered resting state connectivity of the self-reflection network in alexithymia (submitted). Lako I., Taxis K., Bruggeman R., Wiersma D., Slooff C (2010). The prevalence of depressive symptoms and the effectiveness of antidepressants in routine clinical practice of schizophrenia. Schiz Res. Special Issue 2 nd Biennial Schizophrenia International Research Conference, Florence April pp Liemburg EJ., Vercammen A., Knegtering H., Curcic-Blake B., Aleman A (2010). Altered connectivity in auditory and attention systems of schizophrenia patients with auditory hallucinations. Schiz Res. Special Issue 2 nd Biennial Schizophrenia International Research Conference, Florence April pp351. Castelein R., Bruggeman R., van Busschbach JT., Knegtering H., van der Gaag M., Wiersma D., (2010). Predictors of successful participation in peer groups support for psychosis. Poster 2e Schizophrenia International Research Society, Florence April pp Bais L., Hoekert M., Links TP., Knegtering H., Aleman A (2010). Brain asymmetry for emotional prosody in Klinefelter s syndrome. Causal relations investigated with TMS. Poster 2e Schizophrenia International Research Society, Florence April pp Van der Meer L., Pijnenborg M., Nolen WA., Knegtering H., Aleman A (2010). The neural basis of self reflecting processing in schizophrenia patients: an fmri study. Schiz Res. Special Issue 2 nd Biennial Schizophrenia International Research Conference, Florence April. pp 231 Vercammen A., Knegtering H., Liemburg EJ., Boer JA., Aleman A (2010). Functional connectivity of the temporo-parietal region in schizophrenia: Effects of rtms treatment of auditory

2 hallucinations. J Psychiatr Res. Feb 25. [Epub ahead of print] Vercammen A., Knegtering H., Bruggeman R., Aleman A (2010). Subjective Loudness and Reality of Auditory Verbal Hallucinations and Activation of the Inner Speech Processing Network. Schizophr Bull. May 15;67(10): Feb 17. [Epub ahead of print] Modinos G., Vercammen A., Mechelli A., Knegtering H. Aleman A. (2009). Structural covariance in the hallucinating brain: a voxel-based morphometry. In: Gemma Modinos Comellas. Imaging the vulnerable brain, functional and structural MRI in psychosis proneness. PhD thesis Univeristy of Groningen The Netherlands. 26-april 2010; pp Wolters HA., Wiersma D., van den Bosch RJ., Knegtering H. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Schizophr Res Jul;112(1-3): [Epub 2009 Apr 23]. Smid HGOM., Westenbroek JM., Bruggeman R., Knegtering H., van den Bosch RJ (2009). Abnormal externally-guided movement preparation in early-onset schizophrenia is associated with impaired selective attention to external input. Psychiatry Res Nov 30;170(1): [Epub 2009 Sep 16]. Stant D., Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Knegtering H., Wiersma D., Economical aspects of peer support groups for psychosis. Community Ment Health J Mar 24. [Epub ahead of print]. Wolters HA., Wiersma D., van den Bosch RJ., Knegtering H. Effects and side effects of antipsychotic treatment in schizophrenia: pros and cons of available self-rating scales. Abstract for ICOSR congress San Diego (Schizophrenia Research, special issue, March 2009, oral presentation). Stant D., Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Knegtering H., Wiersma D., Economical aspects of peer support groups for psychosis. In: Castelein S. Guided peer support groups for psychosis, a randomized trial. PhD thesis University of Groningen March , page (http://irs.ub.rug.nl/ppn/ ) Castelein S., Bruggeman R., Busschbach JT., Knegtering H., van der Gaag M., Wiersma D. Predictors of successful participation in peer support groups for psychosis. In: Castelein S. Guided peer support groups for psychosis, a randomized trial. PhD thesis University of Groningen March , page (http://irs.ub.rug.nl/ppn/ ) Castelein S., Bruggeman R., Busschbach JT., van der Gaag M., Stant D., Knegtering H., Wiersma D. Th effectiveness of peer support groups in psychosis: A randomized controlled trial. In: Castelein S. Guided peer support groups for psychosis, a randomized trial. PhD thesis University of Groningen March , page (http://irs.ub.rug.nl/ppn/ ) Knegtering H., Ouwehand J., Sytema, S., Wiersma D. (2009). Menstrual disorders in schizophrenia, possible causes and consequences. Abstract for ICOSR congress San Diego (Schizophrenia Research, special issue, March 2009, poster). Knegtering H., Bous J. Psychofarmaca en seksueel functioneren, theorie en praktijk (Psychopharmacology and sexual functioning). Congres bijdrage en gepubliceerd in het congresboek voor de vereniging voor Gynaecologie en Obstetrie. 5 maart Bolle G., Griffioen T., Knegtering H (2009). Seksuologie en psychiatrie (Sexuology and psychiatry). In: Gijs L., Gianotten WL, Vanweesenbeek I., Weijenborg PTM (red). Seksuologie 2 e herzien druk (Dutch Textbook of Sexuology, revised version).houten Bohn Staflleu en van Loghum Modinos G., Vercammen A., Mechelli A., Knegtering H., Aleman A. Structural covariance in the hallucinating brain: A voxel-based morphometry study. Journal of Psychiatry and Neuroscience, Nov;34(6): Knegtering H., Bous, J., Sytema S., Wiersma D (2009). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Report for the Rob Giel Research Center, Lentis Groningen and Bristol Myers Squibb. August Modinos G., Vercammen A., Mechelli A., Knegtering H. Aleman A. (2009). Structural covariance in the hallucinating brain: a voxel-based morphometry. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia. page (http://irs.ub.rug.nl/ppn/ ). Vercammen A. Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia. PhD Thesis University of Groningen, The Netherlands (http://irs.ub.rug.nl/ppn/ ) Vercammen A., Knegtering H., Bruggeman R., Aleman A (2009). Perceptual characteristics of auditory-verbal hallucinations are associated with activation of the inner speech processing network. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal

3 hallucinations in schizophrenia, page (http://irs.ub.rug.nl/ppn/ ) Vercammen A., Knegtering H., Bruggeman R., Westenbroek JM., Jenner JA., Slooff CJ., Wunderink L., Aleman A (2009). Effects of bilateral repetitive Transcranial Magnetic Stimulation (rtms) on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia, page (http://irs.ub.rug.nl/ppn/ ) Vercammen A., Knegtering H., den Boer H., Liemburg E., Aleman A (2009). Functional connectivity of the tempororparietal regions in schizophrenia: associations with auditory-verbal hallucinations and modulations induced by rtms treatment. In: Vercammen A. PhD Thesis: Cognitive and neural processes of auditory-verbal hallucinations in schizophrenia. page (http://irs.ub.rug.nl/ppn/ ). Vercammen A., Knegtering H., Bruggeman R., Westenbroek JM., Jenner JA., Slooff CJ., Wunderink L., Aleman A (2009). Effects of bilateral repetitive Transcranial Magnetic Stimulation (rtms) on treatment resistant auditory-verbal hallucinations in schizophrenia: a randomized controlled trial. Schizophrenia Research 114 (1-3): Hoekert M (2009). Beyond what is being said. Emotional prosody: its neural basis and its relevance for schizophrenia. PhD Thesis, University of Groningen, The Netherlands. (http://irs.ub.rug.nl/ppn/ ). (Supervision A. Aleman (promoter), H. Knegtering (copromotor). Hoekert M., Vercammen A., Kahn R., Knegtering, H., Aleman A (2009). Abarrant attribution of emotional salience to neutral vocal and facial expressions predicts symptomatology in schizophrenia patients. In: Hoekert M (2009). Beyond what is being said. Emotional prosody: its neural basis and its relevance for schizophrenia. PhD Thesis, University of Groningen, The Netherlands. Page (http://irs.ub.rug.nl/ppn/ ). Hoekert M., Scholten M.R.M., Vercammen A., Kahn R.S., Knegtering H., Aleman A (2009). The relation between impaired prosody perceptin and symptom dimensions in schizophrenia. In: Hoekert M (2009). Beyond what is being said. Emotional prosody: its neural basis and its relevance for schizophrenia. PhD Thesis, University of Groningen, The Netherlands. Page (http://irs.ub.rug.nl/ppn/ ) Duisterwinkel G., Bosker F.J., Scholte-Stalenhoef A.N., Vervoort M., Knegtering H. (2008). Antipsychotic augmentation strategies to ameliorate negative and cognitive symptoms in schizophrenia. Central Nervous System Agents in Medical Chemistry. Vol 8 No Knegtering H., van den Bosch R.J., Castelein S., Bruggeman R., Sytema S., van Os J. (2008). Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin. Psychoneuroendocrinology 2008 Jul;33(6): Castelein S., Bruggeman R., van Busschbach J.T., van der Gaag M., Stant A.D., Knegtering H., Wiersma D. (2008). The effectiveness of peer support groups in psychosis. A Randomised controlled trial. Act Psych Scan, 118: Knegtering H., Bruggeman R., Verkes R.J. (2008). Naar een balans tussen gewenste en ongewenste effecten van antipsychotica. (Toward a balance between desired and undesired treatment effects of antipsychotics) In: Verkes R.J., Bruggeman, R (eds). Keuzecriteria voor antipsychotica. Van Zuiden Communications BV, Alphen a/d Rijn. ISBN pp Knegtering H., Bruggeman R. (2008). Het meten van effecten van behandeling. (Evaluation of treatment effects) In: Verkes R.J., Bruggeman R (eds). Keuzecriteria voor antipsychotica. Van Zuiden Communications BV, Alphen a/d Rijn. ISBN pp Knegtering H., Bruggeman R. (2008). Farmacotherapie van psychosen, een handleiding voor de praktijk (Pharmacotherapy of psychotic disorders, a guideline for daily practice). In: Verkes R.J., Bruggeman. Keuzecriteria voor antipsychotica. Van Zuiden Communications BV, Alphen a/d Rijn. ISBN pp Smid HGOM., De Witte MR., Bruggeman R., Knegtering H., van den Bosch RJ (2008). Impairment of switching the focus of attention in recent onset schizophrenia. (Submitted June 2008 to Journal of Psychiatry and Neuroscience). Castelein S., Bruggeman R., van Busschbach J.T., van der Gaag M., Stant A.D., Knegtering H., Wiersma D. (2008). Het effect van lotgenotengroepen voor mensen met een psychose; een multi-centre-rct (The effectiveness of peer support groups in psychosis. A multi-center RCT). Voorjaarscongres Nederlandse Vereniging voor Psychiatrie (Annual Spring Congress of the Dutch Psychiatric Association). Tijdschrift voor Psychiatrie 50 (suppl1) S

4 Castelein S., Bruggeman R., van Busschbach J.T., van der Gaag M., Stant A.D., Knegtering H., Wiersma D. (2008). The effectiveness of peer support groups in psychosis: a randomized controlled trial. Schizophrenia Research 102/1-3 suppl 2, 253. Knegtering H., Bous, J., Sytema S., Wiersma D. (2008). Risperidon, aripiprazole en seksueel functioneren. (Risperidone, aripiprazole and sexual performance). Voorjaarscongres Nederlandse Vereniging voor Psychiatrie. Poster on the Annual Spring Congress of the Dutch Psychiatric Association. Tijdschrift voor Psychiatrie 50 (suppl1) S335. Knegtering H., van den Bosch R.J., Castelein S., Bruggeman R., Sytema S., van Os J. (2008). Are sexual side effects of prolactin-raising antipsychotics reducible to serum prolactin. First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 239. De Lange J, Kuipers M, Knegtering H. (2008). Does the Critical Flicker Fusion Threshold distinguish patients with schizophrenia from healthy controls? First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, De Lange J, Knegtering H, Aleman A (2008). Rapid Transcranial Magnetic Stimulation (r-tms) for negative and cognitive symptoms in schizophrenia, a meta-analyses. Oral presentation at the First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, Wunderink A., Nienhuis F., Sytema SW., Slooff C., Knegtering H., Wiersma D (2008). Guided discontinuation versus maintenance treatment in remitted First episode psychosis: relapse rates and functional outcome. Oral presentation at the First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, Knegtering H., Bous, J., Sytema S., Wiersma D. (2008). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Poster on the Annual Spring Congress of the Dutch Psychiatric Association and on the First Schizophrenia International Research Society Conference. Venice June 21/25. Schizophrenia Research 102/1-3 suppl 2, 238. Klein R., Doorduin J., Knegtering H., de Groot JC., Dierckx RA., de Vries EFJ (2008). Profound inflammatory response in the CNS of psychotic patients. Schizophrenia Research 102/1-3 suppl 2, Knegtering H., Bruggeman R (2007). What are the effects of antipsychotics on sexual functioning? Primary Psychiatry 14(2), Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma D (2007). Guided discontinuation versus maintenance treatment in remitted first episode psychosis: relapse rates and functional outcome. The Journal of Clinical Psychiatry 68;5: Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma D (2007). Guided discontinuation versus maintenance treatment in remitted first episode psychosis: relapse rates and functional outcome. In: Antipsychotic treatment strategies and early course of first episode psychosis, PhD Thesis Lex Wunderink Bruggeman R., Slooff C.j., Taxis K., Knegtering H., Delespaul P., The Phamous-workgroup. De Pharmacotherapy Monitoring and Outcome Survey: Phamous, opzet en eerste resultaten (Pharmacotherapy Monitoring and Outcome Survey: PHAMOUS, design and first results). Voorjaarscongres Nederlandse Vereniging van Psychiatrie, Maastricht 12 April Annual Spring Congress of The Dutch Psychiatric Society. Abstract book pages S Knegtering H., Bruggeman R (2007). Sexual dysfunction and antipsychotics how to bring up the issue when talking to your patients. Advances in schizophrenia and clinical psychiatry, Vol 3 No 1: Knegtering H (2007). Negative and Cognitive Symptoms in Schizophrenia, research and treatment. Doorwerth, Annual Dutch Endo-Neuro-Psycho Meeting. Abstract book page 108. Knegtering, H., Bruggeman, R., Castelein, S., Wiersma D. (2007A). Antipsychotica en seksueel functioneren in mensen met een psychotische stoornis (Antipsychotics and sexual functioning in persons with psychosis). Tijdschr Psychiatr. 2007;49(10): Knegtering, H., & Bruggeman, R. (2007B). What are the effects of antipsychotics on sexual functioning. Primary Psychiatry febr;14(2): Knegtering H., Bous J., Sytema S., Wiersma D (2007). A randomized open-label comparison of the impact of aripiprazole versus risperidone on sexual functioning (RAS study). Report made by the research team of The University Medical Centre of Groningen for Brystol-Meyers Squibb. December

5 Moolen van der A.E.G.M., Bruggeman R., Knegtering H (2007). Overdracht; over voorlichting in de psychiatrie: van theorie naar praktijk (About Health Education in Psychiatry). Boek geschreven in opdracht van afdeling psychosen Universitair Medisch Centrum Groningen (Book written for the department of psychiatry of the University Medical Center in Groningen), ISBN/EAN Castelein S., Bruggeman R., Busschbach van J., van der Gaag M., Stant D., Knegtering H., Wiersma D (2007). The effectiveness of peer support groups in psychosis: a randomized controlled trial effect of peer support groups in psychosis. Schiz Bull submitted. Kemperman R.F.J., Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema M.R., Kema I.P., Korf J., Muskiet F.A.J. Low essentail fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. In: Nutitrion and biomarkers in psychiatry. Kemperman R.F.J PhD Thesis ISBN (electr. vers ). p Kemperman R.F.J. Gouverneur B.J.G.M. Hoekstra Y.T.A., Bruggeman R., Knegtering H., Muskiet F.A.J. (2007). Relations between nicotinate-induced skin flush, erythrocyte fatty acids, serum phospholipase A2 activity and psychopathology in patients with schizophrenia. Poster International Federation of Clinical Chemistry. Hoekstra Y.T., Gouverneur B., Kemperman R., Bruggeman R., Knegtering H., Muskiet F (2007). Niacin skin flush and erythrocyte fatty acid composition in patients with schizophrenia related psychosis. Poster, International Congress on Schizophrenia Research, Colorado Springs. Schizophrenia Bulletin Vol 33 No Wunderink L., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma (2007). Guided Discontinuation versus maintenance treatment in remitted first episode psychosis: relapse rates and functional outcome. Poster, International Congress on Schizophrenia Research, Colorado Springs. Schizophrenia Bulletin Vol 33 No Knegtering H., Wolters H., Wiersma D (2007). Antipsychotics and quality of life, something to worry about? Poster, International Congress on Schizophrenia Research, Colorado Springs. Schizophrenia Bulletin Vol 33 No Knegtering H. Boks M., Blijd C., Castelein C., van den Bosch RJ (2006). A randomized open-label comparison of the impact of olanzapine versus risperidone on sexual functioning. J. Sex Marital Ther 32(4): Wolters HA., Knegtering H., Wiersma D., van den Bosch, RJ (2006). The evaluation of the Subjects Reaction to Antipsychotics (SRA) questionnaire. Int Clin Psychopharmacol. 21(1):63-9. Kemperman RFJ., Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema MR., Kema IP., Korf J., Muskiet FAJ (2006). Low essential fatty acid and B-vitamin status in a subgroup of patients with schizophrenia and its response to dietary supplementation. Prostaglandines, Leukotrienes and Essential Fatty Acids. Feb;74(2): Bruggeman R., Laar van T., Knegtering H (2006). De rol van neurotransmitters bij het ontstaan van hallucinaties (The role of neurotransmitters in the origin of hallucinations). In: Jenner J.A. Hallucinaties, kenmerken, verklaringen behandeling. Koninklijke Van Gorcum, Assen, pp Bruggeman R., Knegtering H (2006). Medicamenteuze behandeling van hallucinaties (Pharmacological treatments options in hallucinations). In: Jenner J.A. Hallucinaties, kenmerken, verklaringen behandeling. Koninklijke Van Gorcum, Assen, pp Zempleni M., Bruggeman R., Knegtering H., van den Bosch R., Stowe L (2006). Comprehension of idiomatic and non-idiomatic sentences in schizophrenia: results of a pilot fmri study. In: Monika Z. Zempleni,. Functional imaging of the hemispheric contribution to language processing. PhD Thesis, University of Groningen, Bosveld van Haandel L., Knegtering H., Kluiter H., van den Bosch RJ (2006). Niacin skin flushing in schizophrenic and depressed patients and healthy controls. Psychiatry Research. 143(2-3): Knegtering, H. Gewenste en ongewenste effecten van antipsychotica: Lezing Parnassia Den Haag, februari Knegtering H. Dwangmedicatie bij psychosen, tussen dwaling en doelmatigheid. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 6 april Wunderink A, Nienhuis J.J., Sytema S., Slooff C.J., Knegtering H., Wierma D. Targeted treatment revisited: een RCT bij eerste psychosen. Uitkomsten en implicaties van de MESIFOS studie. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 6 april Knegtering H., Bruggeman R. Psychofarmacotherapie bij negatieve en cognitieve symptomen. Lezing

6 voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 5 april Wolters H.A., Knegtering H., Wiersma D., Bruggeman R. De SRA-q vragenlijst als hulpmiddel bij het afwegen van voor- en nadelen van antipsychotica: van effectivity naar effectiveness. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 5 april Castelein S., Bruggeman R., Busschbach J.T., Mulder P.J., Gaag van der M., Knegtering H., Wiersma D. Effectiviteit van lotgenotengroepen voor mensen met een psychose. Lezing voorjaarcongres Nederlandse Vereniging voor Psychiatrie, 5 april Knegtering H. Farmacologie en patiënten perspectief. Universitair Medisch Centrum Nijmegen Knegtering H. Gewenste en ongewenst effecten van antipsychotica vanuit farmacologisch perspectief, focus op seksuele functiestoornissen AMC/De Meren Amsterdam. Knegtering H. Gewenste en ongewenst effecten van antipsychotica vanuit farmacologisch perspectief Mentrum Amsterdam. Castelein S., Bruggeman R., Busschach van J.T., Gaag van der M., Knegtering H., Wiersma D (2006). The effectiviveness of professionally guided self-help groups: a multi-center randomized controlled trial. Schiz Res Vol 81. Suppl Knegtering H, De Hert M., Scholte-Stalenhoef A., Werf-Elderink van der M (2006). Schortterm and longterm effects of antipsychotics on prolacin. Schiz Res Vol 81. Suppl Knegtering H, De Hert M., Scholte-Stalenhoef A., Werf-Elderink van der M (2006). Prolactin levels during shortterm and longterm antipsychotic treatment. Schiz Res Vol 81. Suppl Zempleni M.Z., Bruggeman R., Knegtering H., Velzen van M., Bosch van den R.J., Stowe L.A (2006). Comprehension of idioms in schizophrenia, preliminary fmri results. Schiz Res Vol 81. Suppl Knegtering H., Telleman L., Ouwehand J., Crom G., Bruggeman R., Wunderink L., Douwes A., Wiersma D (2006). Caregivers distress and their appraisal of psychoeducation in patients with a first psychotic episode. Schiz Res Vol 81. Suppl Wunderink A., Nienhuis F.J., Sytema S., Slooff C.J., Knegtering H., Wiersma D (2006). Targeted treatment revisited: results of a RCT in first episode psychosis. Schiz Res Vol 81. Suppl Wolters H.A., Knegtering H., Wiersman D., Bosch van den R.J (2006). The quest for quality of life: Subjects Response to Antipsychotics or Symptoms. Schiz Res Vol 81. Suppl Schorr G.S., Bruggeman R., Knegtering H, Janssen R.A., Brouwers J.R.B.J. Taxis K. (2006). Pharmacotherapy with antipsychotics: a monitoring and outcome survey (PHAMOUS)- preliminary results. Kennisceuntrum schizofrenie congres Zwolle Boks MPM (2005). Neurological soft signs in schizophrenia and mood disorders: investigating a potential endophenotype. PhD Thesis University of Groningen, The Netherlands. (http://irs.ub.rug.nl/ppn/ x). (Supervision D. Wiersma (promotor), R.J. van den Bosch (promotor), H. Knegtering (co-promotor). Kemperman R., Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema MR., Kema IP., Korf J., Muskiet FA. (2005). Essential fatty acid and b-vitamin status in schizophrenia. Schizophrenia Bulletin 31(2):251. Smid HG., Bruggeman R., Knegtering H., van Burgel J., van den Bosch RJ (2005). Schizophrenia symptoms, schizotypy, vulnerability factors and cognitive efficacy in first onset schizophrenia patients and healthy controls. Schizophrenia Bulletin 31(2):377. Castelein S., Bruggeman R., van Busschbach JT., van der Gaag M., Mulder PJ., Knegtering H., Wiersma D. (2005). Schizophrenia Bulletin 31(2): Wolters H., Knegtering H., Wiersma D., van den Bosch RJ. (2005). Quality of life and patients evaluation of antipsychotic medication. Schizophrenia Bulletin 31(2): Knegtering H., Wolters HA., Bruggeman R., van den Bosch RJ., Wiersma D. (2005) The subjects responses to antipsychotics evaluator: SRAe. Schizophrenia Bulletin 31(2):565. Knegtering H., Baselmans P., Castelein S., Bosker F., Bruggeman R., Bosch van den RJ (2005). The 9-OH-metabolite of risperidone has a predominant role in elevating blood prolactin levels. Am J Psychiatry. 162(5): Rijcken CA., Knegtering H., Bruggeman R., Tobi H., de Jong-van den Berg LT. (2005). Sex differences in concomitant medication with benzodiazepines or antidepressants in first-break schizophrenic patients treated with antipsychotic medication. Psychiatry Res Apr 15;134(2): Wolters HA., Knegtering H (2005). Frequentie en ernst van ongewenst effecten bij antipsychotica gebruik (Frequency and burden of undesired effects of antipsychotics). In: Slooff CJ., Withaar

7 F., van der Gaag M (Editors). Terugvalpreventie bij schizofrenie en verwante psychosen. Uitgave kenniscentrum schizofrenie (Relapse prevention in schizophrenia and related psychosis). Pagina Knegtering H., Bruggeman R., Castelein S (2005). Antipsychotica en seksueel functioneren bij mensen met psychotische stoornissen (Antipsychotics and sexual functioning in people with psychosis). In: Slooff CJ., Withaar F., van der Gaag M (Editors). Terugvalpreventie bij schizofrenie en verwante psychosen (Relapse prevention in schizophrenia and related psychosis). Uitgave kenniscentrum schizofrenie. Pagina Knegtering H., Bloemendaal M., Bokern H., Dethmers M., Dijkslag C., Joanroy S., Kamphuis R., Klein H., Noppers A., Vels G., Verster M., Raaijmakers C. (2005). Zorgprogramma Psychotische Stoornissen Groningen, een update. Gewijzigde versie eindrapport van de Taakgroep Zorgprogramma Psychotische Stoornissen (Report on a district treatment programm for psychotic disorders). Knegtering H., Bruggeman R. (2005). Meetinstrumenten bij psychotische stoornissen. In: Editor: Wunderink. L. Schizofrenie deel 2, diagnostiek en behandeling. Mark Two Communications bv. ISBN Kemperman R.F.J.,Veurink M., van der Wal T., Knegtering H., Bruggeman R., Fokkema M.R., Kema I.P., Korf J.,Muskiet F.A.J (2004). Essential fatty acid and B-vitamin status in schizophrenia. Poster Spring Congress Dutch Psychiatric Association. Knegtering, H., Castelein, S., Bous, J., Linde van der, J., Bruggeman, R., Kluiter, H., and Bosch van den, RJ. (2004) Randomized Open-Label Study of the Impact of Quetiapine versus Risperidone on Sexual Functioning. J Clin Psychopharmacology Vol 24 Number 1 Febr pp Boks MP., Liddle PF., Burgerhof JG., Knegtering H., Bosch RJ. (2004) Neurological soft signs discriminating mod disorders from first episode schizophrenia. Acta Psychiatr Scan. 110(1) pp Knegtering H.,Bruggeman R., Castelein S (2004). Antipsychotica en seksueel functioneren in mensen met schizofrenie (Antipsychotics and sexual functioning in people with schizophrenia). Tijdschrift voor seksuologie Vol 28,3: Knegtering H., Bruggeman R (2004). Meetinstrumenten bij psychosen (Instruments evaluating psychosis).tijdschrift voor Psychiatrie Vol Knegtering H., Kluiter H (2004). Werken de nieuwe-generatie antipsychotica beter dan de oudere antipsychotica bij schizofrenie of schizoaffectieve stoornis? (Are the newer antipsychotics more effective than the older ones in the treatment of schizophrenia or schizoaffective disorder?). Maandblad Geestelijke volksgezondheid, Vol Wolters, H.A., Knegtering, H., Wiersma, D., van den Bosch, R.J.(2004). A Valid and reliable instrument for measuring the subjective response to antipsychotic medication. Schiz Res Vol 67 No 1 suppl Knegtering, H., Bosveld-van Haandel, L.J.M., Kluiter,H., Bruggeman,R., Castelein,S., van den Bosch, R.J. ( 2004). Is the niacin skin flushing test a tool in the diagnosis of schizophrenia? Schiz Res Vol 67 No 1 suppl Bruggeman, R., Kamphuis, J.R., Castelein, S., Knegtering, H.(2004). Do atypical antipsychotics differentially affect bone mineral density? Schiz Res Vol 67 No 1 suppl Castelein, S., Knegtering, H., Beintema, H., Dost, S., Klene, M., Drenth, B., van den Bosch, R.J., (2004). The long-term effects of depot antipsychotics or clozapine on sexual functioning. Schiz Res Vol 67 No 1 suppl Knegtering H., Bloemendaal M., Bokern H., Dethmers M., Dijkslag C., Joanroy S., Kamphuis R., Klein H., Noppers A., Vels G., Verster M., Raaijmakers C. (2004). Eindrapport van de Taakgroep Zorgprogramma Psychotische Stoornissen (Report on a district treatment programm for psychotic disorders) Bruggeman, R., Knegtering, H., Baselmans, PC., Bous, J., and Castelein, S., Differential effects of 9-OH-risperidone on prolactin elevation; an indicator for drug monitoring? Schizophrenia Research. Vol 60. No. 1 Special Issue pp Castelein, S., Bruggeman, R., Mulder, PJ., and Knegtering, H., Usefulness of semi-structured support groups in schizophrenia. Schizophrenia Research. Vol 60. No. 1 Special Issue pp Boks MP., Liddle PF., Russo S., Knegtering H., Bosch RJ. (2003) Influence of antipsychotic agents on

8 neurological soft signs and dyskinesia in first episode psychosis. Psychiatry Res 15;119(1-2): Bous, J., Castelein, S., Kluiter, H., Testke, A., and Knegtering, H., The antipsychotics and sexual functioning questionnaire (ASFQ): a pilot study evaluating reliability and validity in patients treated with antipsychotics. Schizophrenia Research. Vol 60. No. 1 Special Issue pp Knegtering, H., Castelein, S., Linde van der, J., Bous, J., Bruggeman, R., and Bosch van den, RJ., Sexual dysfunctions and prolactin levels in patients using classical or modern antipsychotics. Schizophrenia Research. Vol 60. No. 1 Special Issue pp Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., Experiences of patients with antipsychotic medication: a questionnaire. Schizophrenia Research. Vol 60. No. 1 Special Issue pp Knegtering, H., Slooff, CJ., Bruggeman, R., Arends, J., Withaar, F., and Wolff, H. (2003) Behandelprotocollen bij schizofrenie en verwante psychosen (treatment protocols in schizophrenia and related psychotic disorders). Kenniscentrum Schizofrenie, Groningen-Assen- Den Haag, Schizofreniestichting Nederland, Koninklijke van Gorkum ISBN Knegtering H., Melman, CTM. (2003) A flexible dose trial with risperidone in early psychotic patients (RIS-NED 16), report for Janssen-Cilag. Wolters HA., H. Knegtering, D. Wiersma, R. J. van den Bosch (2003). The spectrum of subjective effects of antipsychotic medication. Acta Neuropsychiatrica. Vol 15(5) pp: Knegtering H. Antipsychotic treatment and sexual functioning, role of prolactin. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands). Rijcken CAW., Knegtering H., Westerink BHC, Berg van den PB., Tobi H., Jong de Berg van den LTW. The estrogen hypothesis extrapolated: what drug-utilistation studies can add to the theory. In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp Rijcken CAW., Knegtering H., Bruggeman R., Tobi H., Jong de Berg van den LTW. (2003) Concomitant psychotrophic drug use among first-break patients with schizophrenia: the sex differences. In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp (Psychiatry Research, in press) Rijcken CAW., Dekens-Konter JAM., Knegtering H., Bruggeman R., Jong de Berg van den LTW. (2003) Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy? In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands). Rijcken CAW., Veur van der H., Knegtering H., Jong de Berg van den LTW. (2003) Schizophrenia care and the dutch community pharmacy: the unmet needs. In: Claudia Rijcken: Pharmamacy data as tool for assessing antipsychotic drug use. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp (Int J of Pharmacy Practice 2003,6.). Holthausen EAE., Wiersma D., Knegtering H., Bosch van den RJ. (2003) Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. In: Esther Holthausen. Cognition in recent onset schizophrenia. Proefschrift Universiteit Groningen (Ph.D thesis University of Groningen, The Netherlands) pp Gaag van der M., Faber G., Knegtering H. (2003) Schizophrenia Research, verslag van de International Conference on Schizophrenia Research (Congress review), Verenigde Staten, 30 Maart t/m 2 april Maandblad Geestelijke Volksgezondheid, nr 10. pp Knegtering H., Bruggeman R. (2003) Welk (depot) neurolepticum is een goede keus bij een chronisch psychotische patiënt met epilepsie die fenytoine en carbamazepine gebruikt? (Which antipsychotic medication is a good choice in patients with a chronic psychotic illness and epilepsy being treated with fenytoine and carbamazepine?). Apothekers Vademecum, Nummer 3. Knegtering H., van der Moolen AE, Castelein S., Kluiter H., van den Bosch R.J. (2003). What are the effects of antipsychotics on sexual dysfunctions and endocrine functioning? Psychoneuroendocrinology Apr;28 Suppl 2: Review.

9 2002 Knegtering, H., Castelein, S., Linde van der, J., and Bous, J., Sexual dysfunctions and serum prolactin levels in patients using risperidone or quetiapine: a randomised trial. Schizophrenia Research. Vol 53. No 3. Special Issue pp Knegtering, H., Castelein, S., Linde van der, J., and Bous, J., Sexual dysfunctions and antipsychotics. Schizophrenia Research. Vol 53. No 3. Special Issue pp Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., Does cognition predict outcome and course of illness in schizophrenia? Schizophrenia Research. Vol 53. No 3. Special Issue pp Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., Are long-term memory deficits a primary dysfunction in schizophrenia? Schizophrenia Research. Vol 53. No 3. Special Issue pp Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., A questionnaire for patients evaluation of antipsychotic medication. Schizophrenia Research. Vol 53. No 3. Special Issue pp Castelein, S., Jong de, A., Mulder, PJ., Bruggeman, R., and Knegtering, H., Fellow-sufferers: a support-group for young people suffering from psychosis. Schizophrenia Research. Vol 53. No 3. Special Issue pp Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., Subjective reactions on antipsychotics. Poster, spring congress Dutch Psychiatric Association. Congress-book Castelein, S., Mulder, PJ., Jong de, A., Bruggeman, R., and Knegtering, H., Are supportgroups for people with a psychosis, useful? Poster, spring congress Dutch Psychiatric Association. Congress-book Knegtering, H., Boks, M., Blijd, C., Wiersma, D., and Bosch van den, RJ., Sexual dysfunctions in patients using risperidone or olanzapine: a randomized trial. Schizophrenia Research. 49 (NOS 1-2 supplement):285. Castelein, S., Boks, M., Jong de, P., Bruggeman, R., Knegtering, H., and Bosch van den RJ., Obstetric complications and neurological soft signs in patients with schizophrenia. Schizophrenia Research. 49 (NOS 1-2 supplement): Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., Compensation of neurocognitive deficits: influence on course of illness in schizophrenia. Schizophrenia Research. 49 (NOS 1-2 supplement):109. Wolters, HA., Knegtering, H., Wiersma, D., and Bosch van den, RJ., Patients experiences with antipsycotic medication. Schizophrenia Research. 49 (NOS 1-2 supplement): 291. Rijcken, CAW., Dekens-Konter, JAM., Knegtering, H., and Jong de-berg van den, LTW., Reporting sexual function disorders caused by antipsychotic drugs: is there a role for the community pharmacy? Pharmacy, World and Science. 23(5): Rijcken, CAW., Knegtering, H., Bruggeman, R., and Jong de-berg van den, LTW., Observational follow-up study of a cohort of antipsychotic users: are there sex differences in comedication in first-psychosis? Pharmaco-epidemiology and Drug Safety.10:S60. Huusen, EM., Knegtering, H., Slooff, CJ., and Kappert, J., Atypical antipsychotics and weight gain: incidence, ethiology and treatment modalities. Acta Neuropsychiatrica. Vol. 13, no 4, Knegtering, H., Bruggeman, R., and Wolff, H., Behandelprotocollen bij schizofrenie en verwante psychosen. (Treatment protocols in schizophrenia an related psychotics disorders; Chapter in a book on psychopharmocology) In: A.J.L.M. van Balkom, P.N. van Harten, P. Kölling, P. Moleman. Behandeling met psychofarmaca: voorbeelden uit de dagelijkse praktijk. Bohn Stafleu van Loghum Houten/Diegem pp Knegtering, H., Blijd, C., Boks, MPM., Sexual dysfunctions and prolactin levels in patients using risperidone or olanzapine. Schizophrenia Research. Vol 41 No 1,196. Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., Do schizophrenic patients without neuropsychological deficits still show signs of cognitive decline? Schizophrenia Research. Vol 41 No 1, 269. Knegtering, H., Lambers, PA., Prakken, G., and Brink ten, C., Serum prolactin levels and sexual dysfunctions in antipsychotic medication, such as risperidone: a review. Acta Neuropsychiatrica.

10 Vol 12 No 1, Boks, MPM., Knegtering, H., Haaxma, R., and Bosch van den, RJ. et al, The specificity of neurological signs in schizophrenia: a Review. Schizophrenia Research. 43/2-3, Knegtering, H., Boks, MPM., Blijd, C., Wiersma, D., and Bosch van den, RJ., Sexual dysfunctions in patients on antipsychotics. Syllabus & Proceedings Summary, America Psychiatric Association, 2000 Annual Meeting. P and earlier work Gleich van, J., and Knegtering, H., Minder kanker bij schizofrenie? (Less cancer in schizophrenia?) Tijdschrift voor Psychiatrie. Vol 41, No2, Knegtering, H., Blijd, C., and Boks, MPM., Sexual dysfunctions and prolactin levels in patients using classical antipsychotics, risperidone or olanzapine. Schizophrenia Research. Vol. 36 NOS.1-3, Holthausen, EAE., Wiersma, D., Knegtering, H., and Bosch van den, RJ., Psychopathology and cognition in schizophrenia spectrum disorders: the role of depressive symptoms. Schizophrenia Research. Vol. 39, Nolen, WA., and Knegtering, H., Farmacotherapie bij de manisch depressieve stoornis (Pharmacotherapy in bipolar disorders; Chapter in a book on bipolar disorders) In: Boer den, JA. et al. (Eds). Handboek Stemmingsstoornissen Maarsen: Elsevier/De Tijdstroom. Knegtering, H., Boks, M., and Brink ten, C., Sexual dysfunction and serum prolactin levels in patients using classical antipsychotics or risperidone. Poster presentation ninth biennial winter workshop on schizophrenia. Schizophrenia Research. Vol 29. NOS Boks, MPM., Knegtering, H., Haaxma, R., and Bosch van den, RJ., Neurological signs in patients with a first episode of psychosis and healthy controls. Poster presentation ninth biennial winter workshop on schizophrenia. Schizophrenia Research. Vol 29. NOS Brink ten, C., Haan de, L., and Knegtering, H., Subjectieve ervaringen van patiënte met schizofrenie gerelateerd aan behandeling met antipsychotica (subjective experiences of patients with schizophrenia related to the use of antipsychotics). Tijdschrift voor psychiatrie. Vol Knegtering, H., Boks, MPM., and Brink ten, C., Gender specific sexual dysfunctions and serum prolactin levels in patients using classical antipsychotics or risperidone. Poster presentation in the Annual congress of the Dutch Psychiatric Association. Knegtering, H., Boks, M., and Brink ten, C., Sexual dysfunction and serum prolactin level in patients using classical antipsychotics or risperidone. Poster presentation in the Annual congress of the Dutch Psychiatric Association. Boer den, JC., and Knegtering, H., Tardieve dyskinesie en vitamine E. (Tardive dyskinesia and vitamin E). Tijdschrift voor Psychiatrie. Vol Knegtering, H., Boer, JC., Brink ten, C., Pals-Verlinde, AA., Wijngaarden van, P., and Tulner, D., Schizofrenie en motorische stoornissen (Schizophrenia and motoric disorders) In: Dr. J.A. den Boer, Prof. Dr. R. J. van den Bosch (Red): Leerboek Schizofrenie, een neurobiologische benadering. pp Knegtering, H., Moleman, P., Pot, HJ., Slaets, JPJ., and Nolen, WA., Biologische behandelmethoden bij de manisch-depressieve stoornis. (Biological treatment options in bipolar disorders; Chapter in a book on treatmentstrategies) In: Dr. W.A. Nolen en E. Knoppert. Behandelstrategieën voor manisch depressieve stoornissen. pp Verhallen, JTCM., and Knegtering, H., Meetinstrumenten voor motorische stoornissen (Instruments evaluating motoric disorders). COBO bulletin. Jaargang 29, nummer 1, pp Knegtering, H., Brink ten, C., Boks, M., and Lambert, P., Classical and atypical antipsychotics and sexual dysfunction in patients with first episode psychosis. In; First Psychotic Episode of Schizophrenia, Congress Abstract Book, Amsterdam. pp. 67. Hoencamp, E., Knegtering, H., Kooy, JJS., and Moolen van der, AEGM., Patient requests and attitude towards neuroleptics. Nordic Journal of Psychiatry. Volume: 49 Pages: Supplement: Suppl. 35 Hoencamp, E., Haffmans, PMJ., Knegtering, H., Duivenvoorden, HJ., and Dijken, WA., Prediction of (non)response in depressed outpatients treated with moclobemide. Report for Roche. Gernaat, HBPE., Haffmans, PMJ., Knegtering, H., and Birkenhager, TK., Tranylcypromine in narcolepsy. Pharmacopsychiatry. 28, Hoencamp, E., Knegtering, H., Kooy, JSS., and Moolen van der, AEGM., Patient requests and attitude towards neuroleptics. European Neuropsychopharmacology. Volume 5, Number 3, pp.

11 Knegtering, H., Eyck, M., and Huijsman, A., The effects of antidepressants on cognitive functioning of elderly patients; a review. Drugs and Aging. 5 (3): Kooy, JJS., Knegtering, H., and Hoencamp, E., Behoefte aan zorg en waardering van zorg bij patiënten die oraal neuroleptica gebruiken. Een verkennend onderzoek op de polikliniek van het Psychiatrisch Centrum Bloemendaal te Den Haag, Rapport. (Patient requests and attitude towards neuroleptics, an pilot study in the Psychiatric Hospital of Bloemendaal, The Hague, Report). Hoencamp, E., Haffmans, PMJ., Duivenvoorden, H., Knegtering, H., and Dijken, WA., Predictors of (non)response in depressed outpatients treated with a three-phase sequential medication strategy. Journal of Affective Disorders. 31, Knegtering, H., Haffmans, PMJ., Huisman, A., and Eijck, M., The effects of fluoxetine on the cognitive functioning of elderly depressed patients. Report for Ely Lilly. Haffmans, J., and Knegtering, H., The Selective Reversible Monoamine Oxidase-A Inhibitor Brofaromine and Sleep. Journal of Clinical Psychopharmacology. Vol 13/No 4, Hoencamp, E., Haffmans, P., Duivenvoorden, H., Knegtering, H., and Dijken, W., Predictability of (non-)response in depressed out-patients in a three-phase sequential treatment medication strategy. In het Academisch Proefschrift: Depressed out-patients: efficacy and predictability of response of a three-phase treatment strategy. Promovendus Hoencamp, E., Vrije Universiteit Amsterdam. Moolen van der, AEGM., and Knegtering, H., Behoefte aan zorg en de waardering van zorg. Een exploratief onderzoek op de parkpolikliniek te Rotterdam naar de behoefte aan zorg en de waardering voor de gegeven zorg bij patiënten die depot neuroleptica gebruiken. (Needs for care study in patients using intramuscular depot antipsychotics, report for Lunbeck, The Netherlands). Onderzoek in opdracht van de parkpolikliniek in Rotterdam, gesubsidieerd door Lundbeck, Nederland. Knegtering, H., Eyck, M., Huijsman, A., Hoencamp, E., and Haffmans, J., The Effects of maprotiline and brofaromine on cognitive performance in elderly depressed patients: A pilot study. Poster voorjaarcongres Nederlandse Vereniging van Psychiatrie Tijdschrift voor psychiatrie Haffmans, J., and Knegtering, H., Sleep items of the HRSD in depressed patients treated with brofaromine. Sleep Research. 20A, 576. Haffmans, J., Hoencamp, E., and Knegtering, H Brofaromine in therapy resistant depression. Biol. Psychiatry. 29: 11S:37S Knegtering, H., De computer en het Diagnostic Interview Schedule. Een onderzoek naar de mogelijkheden om in de psychiatrie gestructureerde interviews, zoals de DIS, met behulp van een computer af te nemen. (A study for possibilities in psychiatry for computer assisted diagnostics especially with the Diagnostical Interview Schedule (DIS), a report). Onderzoeksrapport/eindscriptie psychiatrisch ziekenhuis Veldwijk te Ermelo. Knegtering, H., The results on the Expanded Programme of Immunisation (EPI) in Southern Darfur (Sudan) Ed Daien. A field survey for MSF-Belgium and the World Health Organisation. Nyala (Sudan). Knegtering, H., Primary Health Care Rehabilitation. Report concerning the activities of MSF- Belgium in the province of Southern Darfur including an activity report especially for Ed Dain district. A report for Medicins Sans Frontieres-Belgium. Nyala (Sudan). H. Knegtering, MD PhD, Groningen May-2010

Conjoint Professor Brian Draper

Conjoint Professor Brian Draper Chronic Serious Mental Illness and Dementia Optimising Quality Care Psychiatry Conjoint Professor Brian Draper Academic Dept. for Old Age Psychiatry, Prince of Wales Hospital, Randwick Cognitive Course

More information

RIJKSUNIVERSITEIT GRONINGEN BOTTOM-UP REHABILITATION IN SCHIZOPHRENIA

RIJKSUNIVERSITEIT GRONINGEN BOTTOM-UP REHABILITATION IN SCHIZOPHRENIA RIJKSUNIVERSITEIT GRONINGEN BOTTOM-UP REHABILITATION IN SCHIZOPHRENIA Proefschrift ter verkrijging van het doctoraat in de Geneeskunde aan de Rijksuniversiteit Groningen op gezag van de Rector Magnificus

More information

Improving the Recognition and Treatment of Bipolar Depression

Improving the Recognition and Treatment of Bipolar Depression Handout for the Neuroscience Education Institute (NEI) online activity: Improving the Recognition and Treatment of Bipolar Depression Learning Objectives Apply evidence-based tools that aid in differentiating

More information

Detailed information and application forms can be found at: www.rug.nl/gmw/rema Applications may be sent to: j.a.m.evers@rug.nl

Detailed information and application forms can be found at: www.rug.nl/gmw/rema Applications may be sent to: j.a.m.evers@rug.nl Brochure Research Master Clinical Psychology /www.rug.nl/psy/onderzoek/onderzoeksscholen/indexhttp://www.rug.nl/ psy/onhttp://www.rug.nl/psy/onderzoek/onderzoeksscholen/indexderzoe k/onderzoeksehtt//www.rug.nl/psy/onderzoek/onderzoeksscholen/index

More information

SAFE BUT SORRY. Theory, assesment, and treatment of pain-related fear in chronic low back pain patients

SAFE BUT SORRY. Theory, assesment, and treatment of pain-related fear in chronic low back pain patients SAFE BUT SORRY Theory, assesment, and treatment of pain-related fear in chronic low back pain patients SAFE but SORRY: Theory, assessment, and treatment of pain-related fear in chronic low back pain patients

More information

Psychotic Disorder. Psychosis. Psychoses may be caused by: Examples of Hallucinations and Delusions 12/12/2012

Psychotic Disorder. Psychosis. Psychoses may be caused by: Examples of Hallucinations and Delusions 12/12/2012 Psychosis Psychotic Disorder Dr Lim Boon Leng Psychiatrist and Medical Director Dr BL Lim Centre For Psychological Wellness Tel: 64796456 Email: info@psywellness.com.sg Web: www.psywellness.com.sg A condition

More information

Schizoaffective Disorder

Schizoaffective Disorder FACT SHEET 10 What Is? Schizoaffective disorder is a psychiatric disorder that affects about 0.5 percent of the population (one person in every two hundred). Similar to schizophrenia, this disorder is

More information

Serious Mental Illness: Symptoms, Treatment and Causes of Relapse

Serious Mental Illness: Symptoms, Treatment and Causes of Relapse Serious Mental Illness: Symptoms, Treatment and Causes of Relapse Bipolar Disorder, Schizophrenia and Schizoaffective Disorder Symptoms and Prevalence of Bipolar Disorder Bipolar disorder, formerly known

More information

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include:

Bipolar Disorder. Mania is the word that describes the activated phase of bipolar disorder. The symptoms of mania may include: Bipolar Disorder What is bipolar disorder? Bipolar disorder, or manic depression, is a medical illness that causes extreme shifts in mood, energy, and functioning. These changes may be subtle or dramatic

More information

This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC.

This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC. This continuing education activity is co-sponsored by Indiana University School of Medicine and by CME Outfitters, LLC. Indiana University School of Medicine and CME Outfitters, LLC, gratefully acknowledge

More information

Chapter 1. Introduction

Chapter 1. Introduction Chapter 1 Introduction 10 Chapter 1 Psychotic depression In this thesis, the term psychotic depression is used to describe severe unipolar major depressive disorder accompanied by delusions and hallucinations,

More information

Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of

Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of Chapter 18 Drugs Used for Psychoses Learning Objectives Identify signs and symptoms of psychotic behavior Describe major indications for the use of antipsychotic agents Identify common adverse effects

More information

THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine

THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine THE DEPRESSION RESEARCH CLINIC Department of Psychiatry and Behavioral Sciences Stanford University, School of Medicine Volume 1, Issue 1 August 2007 The Depression Research Clinic at Stanford University

More information

Publications. Publications in peerreviewed international journals

Publications. Publications in peerreviewed international journals Publications Publications Publications in peerreviewed international journals Hogervorst E, Boshuisen M, Riedel W, Willeken C, Jolles J. 1998 Curt P. Richter Award. The effect of hormone replacement therapy

More information

Dr.Fatima Kamran. Assistant Professor/ Clinical Psychologist

Dr.Fatima Kamran. Assistant Professor/ Clinical Psychologist Dr.Fatima Kamran 650-G, Phase 5, D.H.A, Lahore, Pakistan Home: 00-92-42-35734006 Cell: 00-44-7941095704 f.kamran@surrey.ac.uk, fatimakamran24@yahoo.com Assistant Professor/ Clinical Psychologist University

More information

Emergency Room Treatment of Psychosis

Emergency Room Treatment of Psychosis OVERVIEW The term Lewy body dementias (LBD) represents two clinical entities dementia with Lewy bodies (DLB) and Parkinson s disease dementia (PDD). While the temporal sequence of symptoms is different

More information

New Developments in the Assessment and Treatment of Cognition and Functional Disability

New Developments in the Assessment and Treatment of Cognition and Functional Disability ` New Developments in the Assessment and Treatment of Cognition and Functional Disability Philip D. Harvey, PhD Leonard M. Miller Professor University of Miami Miller School of Medicine Pharvey@med.Miami.edu

More information

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents

Preferred Practice Guidelines Bipolar Disorder in Children and Adolescents These Guidelines are based in part on the following: American Academy of Child and Adolescent Psychiatry s Practice Parameter for the Assessment and Treatment of Children and Adolescents With Bipolar Disorder,

More information

CURRICULUM VITAE EVELIEN PLATJE

CURRICULUM VITAE EVELIEN PLATJE CURRICULUM VITAE EVELIEN PLATJE Personalia Name: Work address: Evelien Platje Leiden University Faculty of Social Sciences Clinical Child & Adolescent Studies PO box 9500 2300 RA Leiden Phone: 0715271252

More information

Local Clinical Trials

Local Clinical Trials Local Clinical Trials The Alzheimer s Association, Connecticut Chapter does not officially endorse any specific research study. The following information regarding clinical trials is provided as a service

More information

Applying ACT to Cases of Complex Depression: New Clinical and Research Perspectives

Applying ACT to Cases of Complex Depression: New Clinical and Research Perspectives Applying ACT to Cases of Complex Depression: New Clinical and Research Perspectives Part I: Depression with Psychosis and Suicidality Brandon Gaudiano, Ph.D. Assistant Professor of Psychiatry Grant Support:

More information

Treatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are:

Treatments for Major Depression. Drug Treatments The two (2) classes of drugs that are typical antidepressants are: Treatments for Major Depression Drug Treatments The two (2) classes of drugs that are typical antidepressants are: 1. 2. These 2 classes of drugs increase the amount of monoamine neurotransmitters through

More information

Antipsychotic drugs are the cornerstone of treatment

Antipsychotic drugs are the cornerstone of treatment Article Effectiveness of Olanzapine, Quetiapine, Risperidone, and Ziprasidone in Patients With Chronic Schizophrenia Following Discontinuation of a Previous Atypical Antipsychotic T. Scott Stroup, M.D.,

More information

, 332-337 CASE REPORT ARIPIPRAZOLE IN PSYCHOTIC DEPRESSION: FOUR CASE REPORTS Kuppuswami Shivakumar, Amna Mir, Victoria D.M. McAllister, Veronica O Keane, Katherine J. Aitchison Summary Object: Aripiprazole

More information

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE 1 Guideline title SCOPE Schizophrenia: core interventions in the treatment and management of schizophrenia in primary and secondary care (update) 1.1

More information

Treatment of Bipolar Disorders with Second Generation Antipsychotic Medications

Treatment of Bipolar Disorders with Second Generation Antipsychotic Medications Neuroendocrinology Letters ISSN 0172-780X Vol. 26, Supplement 1, August 2005 Treatment of Bipolar Disorders with Second Generation Antipsychotic Medications Marek Jarema Ljubomir Hotujac E. Timucin Oral

More information

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE

DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE 1 DEPRESSION CARE PROCESS STEP EXPECTATIONS RATIONALE ASSESSMENT/PROBLEM RECOGNITION 1. Did the staff and physician seek and document risk factors for depression and any history of depression? 2. Did staff

More information

TREATING MAJOR DEPRESSIVE DISORDER

TREATING MAJOR DEPRESSIVE DISORDER TREATING MAJOR DEPRESSIVE DISORDER A Quick Reference Guide Based on Practice Guideline for the Treatment of Patients With Major Depressive Disorder, Second Edition, originally published in April 2000.

More information

DEMENTIA EDUCATION & TRAINING PROGRAM

DEMENTIA EDUCATION & TRAINING PROGRAM The pharmacological management of aggression in the nursing home requires careful assessment and methodical treatment to assure maximum safety for patients, nursing home residents and staff. Aggressive

More information

Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice

Update on guidelines on biological treatment of depressive disorder. Dr. Henry CHEUNG Psychiatrist in private practice Update on guidelines on biological treatment of depressive disorder Dr. Henry CHEUNG Psychiatrist in private practice 2013 update International Task Force of World Federation of Societies of Biological

More information

Comorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014

Comorbid Conditions in Autism Spectrum Illness. David Ermer MD June 13, 2014 Comorbid Conditions in Autism Spectrum Illness David Ermer MD June 13, 2014 Overview Diagnosing comorbidities in autism spectrum illnesses Treatment issues specific to autism spectrum illnesses Treatment

More information

Algorithm for Initiating Antidepressant Therapy in Depression

Algorithm for Initiating Antidepressant Therapy in Depression Algorithm for Initiating Antidepressant Therapy in Depression Refer for psychotherapy if patient preference or add cognitive behavioural office skills to antidepressant medication Moderate to Severe depression

More information

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over

Depression is a common biological brain disorder and occurs in 7-12% of all individuals over Depression is a common biological brain disorder and occurs in 7-12% of all individuals over the age of 65. Specific groups have a much higher rate of depression including the seriously medically ill (20-40%),

More information

Best Practices Treatment Guideline for Major Depression

Best Practices Treatment Guideline for Major Depression Best Practices Treatment Guideline for Major Depression Special Report on New Depression Treatment Technology Based on 2010 APA Practice Guidelines Best Practices Guideline for the Treatment of Patients

More information

Background. Population/Intervention(s)/Comparator/Outcome(s) (PICO)

Background. Population/Intervention(s)/Comparator/Outcome(s) (PICO) updated 2012 Role of anticholinergic medications in patients requiring long-term antipsychotic treatment for psychotic disorders Q6: In individuals with psychotic disorders (including schizophrenia) who

More information

Psychosis Psychosis-substance use Bipolar Affective Disorder Programmes EASY JCEP EPISO Prodrome

Psychosis Psychosis-substance use Bipolar Affective Disorder Programmes EASY JCEP EPISO Prodrome Dr. May Lam Assistant Professor, Department of Psychiatry, The University of Hong Kong Psychosis Psychosis-substance use Bipolar Affective Disorder Programmes EASY JCEP EPISO Prodrome a mental state in

More information

Family Guide To Understanding Antipsychotic Medications Prescribed For Persons With Mental Retardation and Developmental Disabilities

Family Guide To Understanding Antipsychotic Medications Prescribed For Persons With Mental Retardation and Developmental Disabilities Family Guide To Understanding Antipsychotic Medications Prescribed For Persons With Mental Retardation and Developmental Disabilities What are Psychotic Symptoms? Antipsychotic medications are powerful,

More information

Step 4: Complex and severe depression in adults

Step 4: Complex and severe depression in adults Step 4: Complex and severe depression in adults A NICE pathway brings together all NICE guidance, quality standards and materials to support implementation on a specific topic area. The pathways are interactive

More information

Diagnosis 2.0 Towards a new paradigm for personalized mental health care. Marieke Wichers, Psychiatry & Psychology, Maastricht

Diagnosis 2.0 Towards a new paradigm for personalized mental health care. Marieke Wichers, Psychiatry & Psychology, Maastricht Diagnosis 2.0 Towards a new paradigm for personalized mental health care Marieke Wichers, Psychiatry & Psychology, Maastricht Tijd voor een nieuw paradigma in de psychiatrie 1. Van focus op het negatieve

More information

Update on Treatment of the Dementias

Update on Treatment of the Dementias Update on Treatment of the Dementias Mark Pippenger, MD Behavioral Neurology Associate Clinical Professor of Neurology University of Arkansas for Medical Sciences Disclosures I will be discussing off-label

More information

Depression in Older Persons

Depression in Older Persons Depression in Older Persons How common is depression in later life? Depression affects more than 6.5 million of the 35 million Americans aged 65 or older. Most people in this stage of life with depression

More information

Understanding tardive dyskinesia

Understanding tardive dyskinesia Understanding tardive dyskinesia 1 Contents What is tardive dyskinesia? 3 What does TD look like? 3 What might affect the risk of me getting TD? 4 Will TD disappear if I stop my medication? 5 What else

More information

COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA

COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA COMPREHENSIVE MANAGEMENT OF THE ELDERLY PATIENT WITH MANIA Manic depressive illness is a biological brain disorder that produces significant alterations of mood and psychosis. Mania in the elderly occurs

More information

Eating Disorders: Anorexia Nervosa and Bulimia Nervosa Preferred Practice Guideline

Eating Disorders: Anorexia Nervosa and Bulimia Nervosa Preferred Practice Guideline Introduction Eating Disorders are described as severe disturbances in eating behavior which manifest as refusal to maintain a minimally normal body weight (Anorexia Nervosa) or repeated episodes of binge

More information

Integrated Dual Disorder Treatment

Integrated Dual Disorder Treatment Integrated Dual Disorder Treatment In a (Dutch) rapid changing environment Strasbourg May 2010 Bas van der Hoorn b.van.der.hoorn@palier.nl Who s talking? Psychiatrist Head of dual diagnosis treatment facility

More information

OCD & Anxiety: Helen Blair Simpson, M.D., Ph.D.

OCD & Anxiety: Helen Blair Simpson, M.D., Ph.D. OCD & Anxiety: Symptoms, Treatment, & How to Cope Helen Blair Simpson, M.D., Ph.D. Professor of Clinical Psychiatry, Columbia University Director of the Anxiety Disorders Clinic, New York State Psychiatric

More information

Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers

Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers SUPPLEMENT 1: (Supplementary Material for online publication) Antipsychotic drug prescription for patients with dementia in long-term care. A practice guideline for physicians and caregivers About this

More information

Below, this letter outlines [patient name] s medical history, prognosis, and treatment rationale.

Below, this letter outlines [patient name] s medical history, prognosis, and treatment rationale. [Date] [Name of Contact] [Title] [Name of Health Insurance Company] [Address] [City, State, Zip Code] Insured: [Patient Name] Policy Number: [Number] Group Number: [Number] Diagnosis: [Diagnosis and ICD-9-CM

More information

placebo-controlledcontrolled double-blind, blind,

placebo-controlledcontrolled double-blind, blind, Clinical Potential of Minocycline for Depression with Psychotic Features Tsuyoshi Miyaoka Department of Psychiatry Shimane University School of Medicine Minocycline 1. Second-generation tetracycline which

More information

Costing statement: Depression: the treatment and management of depression in adults. (update) and

Costing statement: Depression: the treatment and management of depression in adults. (update) and Costing statement: Depression: the treatment and management of depression in adults (update) and Depression in adults with a chronic physical health problem: treatment and management Summary It has not

More information

List of publications

List of publications List of publications List of publications List of publications L. van Bloemendaal & J.S. ten Kulve, S.E. la Fleur, R.G. IJzerman, M. Diamant. Effects of glucagonlike peptide 1 on appetite and body weight:

More information

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health

PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS. Juanaelena Garcia, MD Psychiatry Director Institute for Family Health PSYCHOPHARMACOLOGY AND WORKING WITH PSYCHIATRY PROVIDERS Juanaelena Garcia, MD Psychiatry Director Institute for Family Health Learning Objectives Learn basics about the various types of medications that

More information

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment

Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Primary Care Update January 28 & 29, 2016 Alzheimer s Disease and Mild Cognitive Impairment Kinga Szigeti, MD Associate Professor UBMD Neurology UB Department of Neurology Questions How do we differentiate

More information

Medications for bipolar disorder

Medications for bipolar disorder Medications for bipolar disorder Findings from Australian National Survey of Mental Health and Wellbeing (Mitchell et al, 2004) In 12 months, only one-third saw a mental health professional 40% received

More information

Long Term Care Formulary HCD - 09. Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine)

Long Term Care Formulary HCD - 09. Anti-Dementia Drugs (e.g. donepezil, galantamine, rivastigmine, memantine) 1 of 8 USE OF CHOLINESTERASE (AChE) INHIBITORS The cholinesterase inhibitor anti-dementia drugs are indicated for the symptomatic treatment of patients with mild to moderate dementia of the Alzheimer s

More information

ISPI Newsletter Archive - Whiplash

ISPI Newsletter Archive - Whiplash ISPI Newsletter Archive - Whiplash March 2005 Widespread Sensory Hypersensitivity Is a Feature of Chronic Whiplash - Associated Disorder but not Chronic Idiopathic Neck Pain. Clin J Pain. 2005 Mar-Apr;21

More information

ATYPICALS ANTIPSYCHOTIC MEDICATIONS

ATYPICALS ANTIPSYCHOTIC MEDICATIONS The atypical antipsychotics are a class of drugs that are used to treat a number of behavioral health disorders, including schizophrenia, other psychotic disorders, mood disorders, and behavioral agitation

More information

Schizoaffective disorder

Schizoaffective disorder Schizoaffective disorder Dr.Varunee Mekareeya,M.D.,FRCPsychT Schizoaffective disorder is a psychiatric disorder that affects about 0.5 to 0.8 percent of the population. It is characterized by disordered

More information

[KQ 804] FEBRUARY 2007 Sub. Code: 9105

[KQ 804] FEBRUARY 2007 Sub. Code: 9105 [KQ 804] FEBRUARY 2007 Sub. Code: 9105 (Revised Regulations) Theory : Two hours and forty minutes Q.P. Code: 419105 Maximum : 100 marks Theory : 80 marks M.C.Q. : Twenty minutes M.C.Q. : 20 marks 1. A

More information

Treatment: Healing Actions, Healing Words

Treatment: Healing Actions, Healing Words Treatment: Healing Actions, Healing Words 15 : Insight-Oriented Therapy Psychoanalysis (p.687) First use of a talking cure Developed by Sigmund Freud Identify unconscious motivations Free association Dream

More information

Curriculum Vitae. Personal details. Date and place of birth:

Curriculum Vitae. Personal details. Date and place of birth: Curriculum Vitae Personal details First name, surname, title: Male/female: Date and place of birth: Nationality: Contact address: Dionne Kessing, MSc Female August 16 th 1985, Enschede, The Netherlands

More information

Dementia & Movement Disorders

Dementia & Movement Disorders Dementia & Movement Disorders A/Prof Michael Davis Geriatrician ACT Health & GSAHS ANU Medical School Eastern Dementia Network Aged and Dementia Care Symposium Bateman s Bay, 22 October 2010 Types of Dementia

More information

Bipolar Disorder: Advances in Psychotherapy

Bipolar Disorder: Advances in Psychotherapy Bipolar Disorder: Advances in Psychotherapy Questions from chapter 1 1) Which is characterized by one or more major depressive episodes with at least one hypomanic episode in which the patient s functioning

More information

Voorspellers en markers bij de Post Myocard Infarct Depressie

Voorspellers en markers bij de Post Myocard Infarct Depressie Voorspellers en markers bij de Post Myocard Infarct Depressie Dorien Tulner NFZP/ACZP symposium, 25 november 2011 MIND- IT The Myocardial InfarcIon and Depression IntervenIon Trial MIND- IT MulI Center

More information

Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD)

Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Delivery of Tobacco Dependence Treatment for Tobacco Users with Mental Illness and Substance Use Disorders (MISUD) Learning Objectives Upon completion of this module, you should be able to: Describe how

More information

M.A.Lips. Copyright 2014, M.A.Lips, Amsterdam, the Netherlands

M.A.Lips. Copyright 2014, M.A.Lips, Amsterdam, the Netherlands Roux-en-Y Gastric Bypass and Calorie Restriction: Differences and Similarities of Endocrine and Metabolic Effects in Obesity and Type 2 Diabetes Mellitus Mirjam Anne Lips Roux-en-Y Gastric Bypass and Calorie

More information

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES

Course Description. SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES Course Description SEMESTER I Fundamental Concepts of Substance Abuse MODULE OBJECTIVES At the end of this course participants will be able to: Define and distinguish between substance use, abuse and dependence

More information

Costs and effects of short-acting atypical and conventional formulations in the Netherlands

Costs and effects of short-acting atypical and conventional formulations in the Netherlands Additionele informatie bij de multidisciplinaire richtlijn Schizofrenie Richtlijn voor de diagnostiek, zorgorganisatie en behandeling van volwassenen cliënten met schizofrenie 2005 Costs and effects of

More information

follow-up of a dose reduction/discontinuation (DR) vs maintenance treatment (MT) trial.

follow-up of a dose reduction/discontinuation (DR) vs maintenance treatment (MT) trial. Research Original Investigation Recovery in Remitted First-Episode Psychosis at 7 Years of Follow-up of an Early Dose Reduction/Discontinuation or Maintenance Treatment Strategy Long-term Follow-up of

More information

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness

Barriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität

More information

New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine

New Treatments. For Bipolar Disorder. Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine New Treatments For Bipolar Disorder Po W. Wang, MD Clinical Associate Professor Bipolar Disorders Clinic Stanford University School of Medicine Abbott Laboratories AstraZeneca Bristol-Myers Squibb Corcept

More information

Psychiatric Comorbidity in Methamphetamine-Dependent Patients

Psychiatric Comorbidity in Methamphetamine-Dependent Patients Psychiatric Comorbidity in Methamphetamine-Dependent Patients Suzette Glasner-Edwards, Ph.D. UCLA Integrated Substance Abuse Programs August11 th, 2010 Overview Comorbidity in substance users Risk factors

More information

Major Depressive Disorder:

Major Depressive Disorder: Major Depressive Disorder: An Actuarial Commercial Claim Data Analysis July 2013 Prepared by: Milliman, Inc. NY Kate Fitch RN, MEd Kosuke Iwasaki FIAJ, MAAA, MBA This report was commissioned by Takeda

More information

GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS

GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS GUIDELINES GUIDELINES FOR USE OF PSYCHOTHERAPEUTIC MEDICATIONS IN OLDER ADULTS Preamble The American Society of Consultant Pharmacists has developed these guidelines for use of psychotherapeutic medications

More information

A Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood.

A Manic Episode is defined by a distinct period during which there is an abnormally and persistently elevated, expansive, or irritable mood. Bipolar disorder Bipolar (manic-depressive illness) is a recurrent mode disorder. The patient may feel stable at baseline level but experience recurrent shifts to an emotional high (mania or hypomania)

More information

The Depression Initiative: New Hope for Recovery from Mood and Anxiety Disorders

The Depression Initiative: New Hope for Recovery from Mood and Anxiety Disorders The Depression Initiative: New Hope for Recovery from Mood and Anxiety Disorders To discuss a gift in support of the Depression Initiative, contact: Susan H. Dana Director of Major Gifts (860) 545-2226

More information

Requirements. Elective Courses (minimum 9 cr.) Psychology Major. Capstone Sequence (14 cr.) Required Courses (21 cr.)

Requirements. Elective Courses (minimum 9 cr.) Psychology Major. Capstone Sequence (14 cr.) Required Courses (21 cr.) PSYCHOLOGY, B.A. Requirements Total minimum number of credits required for a major in leading to the B.A. degree 120. Total minimum number of credits for a minor in psychology 18. Total minimum number

More information

NeuroStar TMS Therapy Patient Guide for Treating Depression

NeuroStar TMS Therapy Patient Guide for Treating Depression NeuroStar TMS Therapy Patient Guide for Treating Depression This NeuroStar TMS Therapy Patient Guide for Treating Depression provides important safety and use information for you to consider about treating

More information

Assessment and Diagnosis of DSM-5 Substance-Related Disorders

Assessment and Diagnosis of DSM-5 Substance-Related Disorders Assessment and Diagnosis of DSM-5 Substance-Related Disorders Jason H. King, PhD (listed on p. 914 of DSM-5 as a Collaborative Investigator) j.king@lecutah.com or 801-404-8733 www.lecutah.com D I S C L

More information

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP)

COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) The European Agency for the Evaluation of Medicinal Products Evaluation of Medicines for Human Use London, 26 April 2001 COMMITTEE FOR PROPRIETARY MEDICINAL PRODUCTS (CPMP) NOTE FOR GUIDANCE ON CLINICAL

More information

information for service providers Schizophrenia & Substance Use

information for service providers Schizophrenia & Substance Use information for service providers Schizophrenia & Substance Use Schizophrenia and Substance Use Index 2 2 3 5 6 7 8 9 How prevalent are substance use disorders among people with schizophrenia? How prevalent

More information

Mohammad Amjad ullah Khan, M.D. Child, Adolescent and Adult Psychiatry Texas A & M University Scott & White Healthcare System Temple and Killeen

Mohammad Amjad ullah Khan, M.D. Child, Adolescent and Adult Psychiatry Texas A & M University Scott & White Healthcare System Temple and Killeen Mohammad Amjad ullah Khan, M.D. Child, Adolescent and Adult Psychiatry Texas A & M University Scott & White Healthcare System Temple and Killeen Sadness of mood for most of the day, nearly every day, and/or

More information

Clinical Audit: Prescribing antipsychotic medication for people with dementia

Clinical Audit: Prescribing antipsychotic medication for people with dementia Clinical Audit: Prescribing antipsychotic medication for people with dementia Trust, team and patient information Q1. Patient's DIS number... Q2. Patient s residence: Home Residential Home Nursing Home

More information

Samantha V. Abram 2433 Lyndale Ave S, Apt 102 Minneapolis, MN 55405 abram221@umn.edu

Samantha V. Abram 2433 Lyndale Ave S, Apt 102 Minneapolis, MN 55405 abram221@umn.edu EDUCATION University of Minnesota, Aug 2012 Present Minneapolis, Minnesota Doctor of Philosophy in Clinical Science & Psychopathology Research Program Advisor: Angus MacDonald III, PhD, Co-Advisor: A.

More information

Pharmacological Management of Prodromal and First Episode Schizophrenia

Pharmacological Management of Prodromal and First Episode Schizophrenia Pharmacological Management of Prodromal and First Episode Schizophrenia The optimal time to treat schizophrenia is as early in the course and as close to the onset as possible. Often the onset of the illness

More information

CLINICIAN INTERVIEW COMPLEXITIES OF BIPOLAR DISORDER. Interview with Charles B. Nemeroff, MD, PhD

CLINICIAN INTERVIEW COMPLEXITIES OF BIPOLAR DISORDER. Interview with Charles B. Nemeroff, MD, PhD COMPLEXITIES OF BIPOLAR DISORDER Interview with Charles B. Nemeroff, MD, PhD Dr Nemeroff is the Reunette W. Harris Professor and Chairman of the Department of Psychiatry and Behavioral Sciences at Emory

More information

College of Education. Rehabilitation Counseling

College of Education. Rehabilitation Counseling * 515 MEDICAL AND PSYCHOSOCIAL ASPECTS OF DISABILITIES I. (3) This course is designed to prepare rehabilitation and mental health counselors, social works and students in related fields with a working

More information

jptrujillo88@hotmail.com 2005 2009 Tulsa Community College (Associate of Arts -Psychology)

jptrujillo88@hotmail.com 2005 2009 Tulsa Community College (Associate of Arts -Psychology) Curriculum Vitae Personal Information Surname: Given Name: Trujillo James Paul Address: Paulinastraat 62 Postal code, city and country: Email: 2595GK, Den Haag, NL jptrujillo88@hotmail.com Date of birth:

More information

Disclosures Christer Allgulander

Disclosures Christer Allgulander How Patients With Generalized Anxiety Disorder (GAD) Are Treated in Specialized Care: A Pharmacoepidemiological Case Register Study in Sweden Christer Allgulander MD, Karolinska Institutet, Sweden Jan

More information

BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS

BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS BRIEF NOTES ON THE MENTAL HEALTH OF CHILDREN AND ADOLESCENTS The future of our country depends on the mental health and strength of our young people. However, many children have mental health problems

More information

Psychosocial Rehabilitation. Presenter : Vikash Ranjan Sharma Mentor: Dr.Triptish Bhatia

Psychosocial Rehabilitation. Presenter : Vikash Ranjan Sharma Mentor: Dr.Triptish Bhatia Psychosocial Rehabilitation Presenter : Vikash Ranjan Sharma Mentor: Dr.Triptish Bhatia Definition A comprehensive process that offers the opportunity for individuals who are impaired, disabled or handicapped

More information

Supplements in Psychiatry: N-Acetylcysteine, Omega-3 Fatty Acids & Melatonin. March 19, 2004 David A. Graeber, MD UNM Department of Psychiatry

Supplements in Psychiatry: N-Acetylcysteine, Omega-3 Fatty Acids & Melatonin. March 19, 2004 David A. Graeber, MD UNM Department of Psychiatry Supplements in Psychiatry: N-Acetylcysteine, Omega-3 Fatty Acids & Melatonin March 19, 2004 David A. Graeber, MD UNM Department of Psychiatry 1 N-Acetylcysteine = NAC NAC modulates Neurotransmitters: 1.

More information

Chapter 10. Summary & Future perspectives

Chapter 10. Summary & Future perspectives Summary & Future perspectives 123 Multiple sclerosis is a chronic disorder of the central nervous system, characterized by inflammation and axonal degeneration. All current therapies modulate the peripheral

More information

Prescribing antipsychotics to older people: report from pilot study

Prescribing antipsychotics to older people: report from pilot study Prescribing antipsychotics to older people: report from pilot study Prepared by Rebecca Harris, bpac nz for PHARMAC September, 2015 bpac nz Prescribing antipsychotics to older people: Report from pilot

More information

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease.

Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Steps to getting a diagnosis: Finding out if it s Alzheimer s Disease. Memory loss and changes in mood and behavior are some signs that you or a family member may have Alzheimer s disease. If you have

More information

Accessing Web Based Health care and Resources for Mental Health: Interface Design Considerations for People Experiencing Mental Illness

Accessing Web Based Health care and Resources for Mental Health: Interface Design Considerations for People Experiencing Mental Illness Accessing Web Based Health care and Resources for Mental Health: Interface Design Considerations for People Experiencing Mental Illness Alice Good & Arunasalam Sambhanthan School of Computing University

More information

Madelon Vollebregt. May, 2014

Madelon Vollebregt. May, 2014 Madelon Vollebregt May, 2014 Personal information Donders Institute for Brain, Cognition and Behaviour Centre for Cognitive Neuroimaging, room 2.24 Kapittelweg 29 6525 EN Nijmegen The Netherlands Email:

More information

Prerequisite: Psychology 1 or 9 or junior or senior standing.

Prerequisite: Psychology 1 or 9 or junior or senior standing. 4 PSY 1-01 & 1-02 Introduction to Psychology This course will survey current knowledge of human behavior. It will cover the entire spectrum of behavioral functions and examine the biological, cognitive

More information

Drugs PSYCHOSIS. Depression. Stress Medical Illness. Mania. Schizophrenia

Drugs PSYCHOSIS. Depression. Stress Medical Illness. Mania. Schizophrenia Drugs Stress Medical Illness PSYCHOSIS Depression Schizophrenia Mania Disorders In preschool children imaginary friends and belief in monsters under the bed is normal (it may be normal in older developmentally

More information